In the second of a two-part series with TB and HIV experts at the Bill & Melinda Gates Foundation, John Donnelly speaks with Dr. Peter Small, who runs the tuberculosis program at the Gates Foundation, regarding his thoughts on recent developments in the field of TB control and treatment, including the promise of the Gene Xpert rapid TB diagnostic tool. Dr. Small is a member of the Stop TB Partnership’s Coordinating Board, has done extensive research in the genetic variability of tuberculosis, and is a global expert in TB epidemiology, biology and control.
More than 150,000 Americans with HIV remain unaware of infection, while PrEP uptake represents fraction of need
With an ambitious, but yet to be funded federal plan to end the American HIV epidemic within the next 10 years in front of Congress, about […]
50th Union World Conference on Lung Health: Vaccine candidate shows effectiveness in preventing active TB disease
HYDERABAD, INDIA – The world is one major step closer to a vaccine against tuberculosis, researchers said here, with results from a clinical trial of an […]
DRC Ebola PHEIC continues amid ongoing obstacles while vaccine approval represents “major milestone” for future responses
While the committee examining the Ebola epidemic in the Democratic Republic of Congo emerged today from its 5th meeting with the conclusion that transmissions of the […]
DRC, Liberia, Madagascar, Somalia and Ukraine account for nearly half of global measles cases Measles incidence increased in five regions around the world between 2016 and […]